Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$728M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$645M |
| 3 |
SPDR Gold Trust
GLD
|
+$413M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$401M |
| 5 |
SpaceX
SPCX
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.91B |
| 2 |
Micron Technology
MU
|
+$1.85B |
| 3 |
NVIDIA
NVDA
|
+$1.69B |
| 4 |
GE Vernova
GEV
|
+$809M |
| 5 |
Advanced Micro Devices
AMD
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.44% |
| 2 | Technology | 22.37% |
| 3 | Financials | 6.09% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Healthcare | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2001
PUT
Solstice Advanced Materials
SOLS
$9.17B
| $5.63M | ﹤0.01% |
+100,000
| New | +$6.06M |
2026 Q3
0 quarters
|
|
2002
CALL
Super Micro Computer
SMCI
$19.4B
| $5.61M | ﹤0.01% |
136,600
-198,400
| -59% | -$6.74M |
2024 Q4
7 quarters
|
|
2003
CALL
DexCom
DXCM
$33B
| $5.61M | ﹤0.01% |
65,000
| – | – |
2022 Q4
15 quarters
|
|
2004
PUT
CVS Health
CVS
$102B
| $5.57M | ﹤0.01% |
65,000
-15,000
| -19% | -$1.47M |
2024 Q4
7 quarters
|
|
2005
Franklin FTSE India ETF
FLIN
$2.67B
| $5.57M | ﹤0.01% |
166,210
+134,879
| +430% | +$4.75M |
2024 Q1
10 quarters
|
|
2006
CALL
Air Products & Chemicals
APD
$71B
| $5.56M | ﹤0.01% |
20,000
| – | – |
2026 Q1
2 quarters
|
|
|
2007
PUT
Air Products & Chemicals
APD
$71B
| $5.56M | ﹤0.01% |
20,000
| – | – |
2026 Q2
1 quarter
|
|
2008
Cytokinetics
CYTK
$8.84B
| $5.55M | ﹤0.01% |
84,191
-238,741
| -74% | -$18.2M |
2013 Q2
53 quarters
|
|
2009
Genworth Financial
GNW
$3.47B
| $5.55M | ﹤0.01% |
618,360
+387,083
| +167% | +$3.82M |
2013 Q2
53 quarters
|
|
2010
Acuity Brands
AYI
$10.1B
| $5.54M | ﹤0.01% |
17,897
-262
| -1% | -$87.2K |
2013 Q2
53 quarters
|
|
2011
Brady Corp
BRC
$3.89B
| $5.53M | ﹤0.01% |
66,276
+49,606
| +298% | +$4.52M |
2013 Q2
53 quarters
|
|
2012
PUT
Whirlpool
WHR
$2.15B
| $5.52M | ﹤0.01% |
180,000
+95,000
| +112% | +$3.61M |
2026 Q1
2 quarters
|
|
2013
FB Financial Corp
FBK
$2.75B
| $5.52M | ﹤0.01% |
106,743
+54,573
| +105% | +$3.14M |
2016 Q4
39 quarters
|
|
2014
CALL
YPF Sociedad Anonima ADS
YPF
$16.3B
| $5.51M | ﹤0.01% |
+110,000
| New | +$5.62M |
2026 Q3
0 quarters
|
|
2015
CALL
Cadence Design Systems
CDNS
$90.4B
| $5.51M | ﹤0.01% |
16,700
-13,300
| -44% | -$4.37M |
2026 Q2
1 quarter
|
|
2016
Griffon
GFF
$4.87B
| $5.51M | ﹤0.01% |
59,224
-6,504
| -10% | -$624K |
2013 Q2
53 quarters
|
|
2017
Nicolet Bankshares
NIC
$3.64B
| $5.5M | ﹤0.01% |
33,741
+8,859
| +36% | +$1.51M |
2017 Q4
35 quarters
|
|
2018
Essential Properties Realty Trust
EPRT
$6.19B
| $5.5M | ﹤0.01% |
212,907
-81,307
| -28% | -$2.45M |
2018 Q2
33 quarters
|
|
2019
Hyatt Hotels
H
$17.8B
| $5.48M | ﹤0.01% |
34,574
-91,761
| -73% | -$16.1M |
2013 Q2
53 quarters
|
|
2020
Helios Technologies
HLIO
$2.21B
| $5.48M | ﹤0.01% |
80,676
+60,314
| +296% | +$4.58M |
2013 Q2
53 quarters
|
|
2021
Concentrix
CNXC
$1.89B
| $5.46M | ﹤0.01% |
219,028
+101,868
| +87% | +$2.66M |
2020 Q4
23 quarters
|
|
2022
Takeda Pharmaceutical
TAK
$67.3B
| $5.46M | ﹤0.01% |
300,375
-96,082
| -24% | -$1.7M |
2018 Q4
31 quarters
|
|
2023
CALL
Snowflake
SNOW
$103B
| $5.43M | ﹤0.01% |
+16,000
| New | +$4.94M |
2026 Q3
0 quarters
|
|
2024
Acadian Asset Management
AAMI
$3.25B
| $5.43M | ﹤0.01% |
59,221
+15,382
| +35% | +$1.36M |
2014 Q4
47 quarters
|
|
2025
PUT
Alnylam Pharmaceuticals
ALNY
$21.6B
| $5.43M | ﹤0.01% |
22,000
-7,900
| -26% | -$2.01M |
2025 Q3
4 quarters
|
|
Similar funds
Citigroup's Q3 2026 Portfolio in Review
As of Q3 2026, Citigroup held 6,419 positions worth $308B, up 1.8% from $303B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2026 filing shows 741 new, 2,043 increased, 2,737 reduced and 437 closed positions. Its largest new stake was SK Hynix Inc: 1,085,406 shares worth $200M. The largest sale was Microsoft, an estimated $1.91B.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- Citigroup's largest Q3 2026 buy was SK Hynix Inc: 1,085,406 shares worth $200M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $728M increase.
- Citigroup's biggest Q3 2026 reduction was Microsoft, cutting an estimated $1.91B.
- Citigroup fully exited Webster Financial in Q3 2026, selling an estimated $273M.
- Citigroup's ten largest holdings make up 21% of its $308B portfolio in Q3 2026.
- Citigroup opened 741 new positions and closed 437 in Q3 2026.
- Citigroup's portfolio value rose 1.8% quarter-over-quarter to $308B.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.